SARS-CoV-2 vaccines-induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?
ABSTRACT The coronavirus disease 2019 (COVID-19) pandemic is significantly causing unprecedented clinical, socioeconomic, and public health challenges globally. The successful global administration of effective, safe and sustainable vaccine(s) is widely believed to be crucial in mitigating as well a...
Saved in:
Main Authors: | Rine Christopher Reuben (Author), Lillian Yami Adogo (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Pregnancy-Associated Thrombotic Thrombocytopenia Purpura
by: Ashley Fyfe-Brown, et al.
Published: (2013) -
An improbable and unusual case of thrombotic thrombocytopenia purpura
by: Jaymon Patel, et al.
Published: (2016) -
A Case of COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia
by: Abhinandan Chittal, et al.
Published: (2021) -
Erythema nodosum :what should we consider about it?
by: Farhang Babamahmoudi, et al.
Published: (2016) -
Inherited Thrombocytopenia Caused by Germline Mutation Should Be Considered in Young Patients With Suspected Myelodysplastic Syndrome
by: Tariq Kewan, et al.
Published: (2020)